Nuvectis Pharma, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
20.67
|
|
Average Rating
|
4.33
|
|
# Strong Buys
|
1
|
|
# Buys
|
2
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2023-03-31
|
-0.30
|
0.00
|
0.30
|
100.00%
|
|
2022-12-31
|
-0.27
|
0.00
|
0.27
|
100.00%
|
|
2022-09-30
|
-0.27
|
-0.42
|
-0.15
|
-55.56%
|
|
2022-06-30
|
-0.23
|
-0.28
|
-0.05
|
-21.74%
|
|
2022-03-31
|
-0.23
|
-0.32
|
-0.09
|
-39.13%
|
|
2021-12-31
|
-0.85
|
-0.48
|
0.37
|
43.53%
|
|
2021-09-30
|
0.00
|
-24.43
|
-24.43
|
0.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.02
|
|
2021-12-31
|
-24.91
|